TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.960
+0.030 (1.55%)
Oct 9, 2026, 4:00 PM EDT - Market closed
TuHURA Biosciences Market Cap
TuHURA Biosciences has a market cap or net worth of $124.9 million as of October 9, 2026. It is the 23,906th most valuable company in the world and the 3,953rd biggest in the United States. Its market cap has decreased by 4.38% in one year.
Market Cap
124.90M
Enterprise Value
133.09M
1-Year Change
-4.38%
Global Rank
Country Rank
#3,953 United States
Category
ChartMarket Cap Chart
Since October 18, 2024, TuHURA Biosciences's market cap has decreased from $264.60M to $124.90M, a decrease of -52.80%. That is a compound annual growth rate of -31.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 124.90M | 171.84% |
| Dec 31, 2025 | 45.95M | -73.43% |
| Dec 31, 2024 | 172.94M | -34.64% |
| Oct 18, 2024 | 264.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 134.27M |
| Spruce Biosciences | 124.92M |
| Tenaya Therapeutics | 124.36M |
| Tonix Pharmaceuticals Holding | 124.17M |
| NRx Pharmaceuticals | 124.16M |
| Seer, Inc. | 122.93M |
| Kazia Therapeutics | 122.92M |
| Foghorn Therapeutics | 121.74M |